These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 16278384)
21. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342 [TBL] [Abstract][Full Text] [Related]
22. Human epithelial ovarian cancer allelotype. Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726 [TBL] [Abstract][Full Text] [Related]
23. Allelotype of human ovarian cancer. Sato T; Saito H; Morita R; Koi S; Lee JH; Nakamura Y Cancer Res; 1991 Oct; 51(19):5118-22. PubMed ID: 1655245 [TBL] [Abstract][Full Text] [Related]
24. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer. Dong Q; Kirley S; Rueda B; Zhao C; Zukerberg L; Oliva E Mod Pathol; 2003 Sep; 16(9):863-8. PubMed ID: 13679449 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854 [TBL] [Abstract][Full Text] [Related]
26. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing. Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814 [TBL] [Abstract][Full Text] [Related]
27. [Ovarian mucinous adenocarcinoma, mucocele of the appendix and pseudomyxoma peritonei: case report with immunohistochemical analysis]. Singh A; Winkler M; Handt S; Rath W Zentralbl Gynakol; 2000; 122(3):175-8. PubMed ID: 10756603 [TBL] [Abstract][Full Text] [Related]
28. Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors. Kerr SE; Flotte AB; McFalls MJ; Vrana JA; Halling KC; Bell DA Am J Surg Pathol; 2013 Aug; 37(8):1229-35. PubMed ID: 23774174 [TBL] [Abstract][Full Text] [Related]
29. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
30. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms. Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875 [TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer is a heterogeneous disease. Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589 [TBL] [Abstract][Full Text] [Related]
34. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318 [TBL] [Abstract][Full Text] [Related]
35. Fractional allelic loss in gastric carcinoma correlates with growth patterns. Choi SW; Park SW; Lee KY; Kim KM; Chung YJ; Rhyu MG Oncogene; 1998 Nov; 17(20):2655-9. PubMed ID: 9840929 [TBL] [Abstract][Full Text] [Related]
36. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780 [TBL] [Abstract][Full Text] [Related]
37. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
38. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases. Hristov AC; Young RH; Vang R; Yemelyanova AV; Seidman JD; Ronnett BM Am J Surg Pathol; 2007 Oct; 31(10):1502-11. PubMed ID: 17895750 [TBL] [Abstract][Full Text] [Related]
39. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913 [TBL] [Abstract][Full Text] [Related]